CN1754872A - 从发酵肉汤中回收抑素化合物的方法 - Google Patents

从发酵肉汤中回收抑素化合物的方法 Download PDF

Info

Publication number
CN1754872A
CN1754872A CNA2005100739122A CN200510073912A CN1754872A CN 1754872 A CN1754872 A CN 1754872A CN A2005100739122 A CNA2005100739122 A CN A2005100739122A CN 200510073912 A CN200510073912 A CN 200510073912A CN 1754872 A CN1754872 A CN 1754872A
Authority
CN
China
Prior art keywords
pravastatin
salt
sodium
acid
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005100739122A
Other languages
English (en)
Chinese (zh)
Inventor
V·科里
L·迪克
I·福加斯
C·斯扎博
E·A·纳格伊内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22609918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1754872(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogal Gyogyszergyar Rt filed Critical Biogal Gyogyszergyar Rt
Publication of CN1754872A publication Critical patent/CN1754872A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNA2005100739122A 1999-11-30 2000-11-28 从发酵肉汤中回收抑素化合物的方法 Pending CN1754872A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16805699P 1999-11-30 1999-11-30
US60/168056 1999-11-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN00818725A Division CN1433305A (zh) 1999-11-30 2000-11-28 从发酵肉汤中回收抑素化合物的方法

Publications (1)

Publication Number Publication Date
CN1754872A true CN1754872A (zh) 2006-04-05

Family

ID=22609918

Family Applications (2)

Application Number Title Priority Date Filing Date
CN00818725A Pending CN1433305A (zh) 1999-11-30 2000-11-28 从发酵肉汤中回收抑素化合物的方法
CNA2005100739122A Pending CN1754872A (zh) 1999-11-30 2000-11-28 从发酵肉汤中回收抑素化合物的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN00818725A Pending CN1433305A (zh) 1999-11-30 2000-11-28 从发酵肉汤中回收抑素化合物的方法

Country Status (22)

Country Link
US (3) US6444452B1 (enExample)
EP (1) EP1265604B1 (enExample)
JP (5) JP3881240B2 (enExample)
KR (1) KR20030026920A (enExample)
CN (2) CN1433305A (enExample)
AT (2) ATE382344T1 (enExample)
AU (1) AU1804601A (enExample)
CA (1) CA2393057C (enExample)
CY (1) CY1105925T1 (enExample)
DE (3) DE60031447T2 (enExample)
DK (1) DK1265604T3 (enExample)
ES (2) ES2273737T3 (enExample)
HR (1) HRP20020454A2 (enExample)
HU (1) HUP0204012A3 (enExample)
MX (1) MXPA02005283A (enExample)
PL (1) PL364918A1 (enExample)
PT (1) PT1265604E (enExample)
RU (1) RU2002114072A (enExample)
SK (1) SK7342002A3 (enExample)
WO (1) WO2001039768A1 (enExample)
YU (1) YU39102A (enExample)
ZA (1) ZA200203912B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
EP1265604B1 (en) * 1999-11-30 2006-10-18 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for recovering statin compounds from a fermentation broth
PL364929A1 (en) * 1999-12-14 2004-12-27 Biogal Gyogyszergyar Rt. Novel forms of pravastatin sodium
MXPA03002963A (es) * 2000-10-05 2005-01-25 Biogal Gyogyszergyar Pravastatina de sodio sustancialmente libre de pravastatina lactona y epi-pravastatina, y composiciones que la contienen.
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
JP2002121172A (ja) * 2000-10-16 2002-04-23 Sankyo Co Ltd プラバスタチン又はその薬理上許容される塩の精製方法
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
JP2003026634A (ja) * 2001-07-17 2003-01-29 Mercian Corp プラバスタチンナトリウム塩の製造方法
US6716615B2 (en) 2002-02-27 2004-04-06 Yung Shin Pharmaceutical Ind. Co., Ltd. Strains of saccharaothrix, process for producing pravastatin using the strains and isolation process of (HMG)-CoA reductase
JP3422791B2 (ja) 2002-08-06 2003-06-30 三共株式会社 プラバスタチンの単離・精製方法
KR100540761B1 (ko) * 2002-08-09 2006-01-16 코바이오텍 (주) 프라바스타틴 나트륨의 제조방법
EP1477471A1 (en) * 2003-05-14 2004-11-17 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Process for purifying pravastin sodium from a fermentation broth
EP2033636A1 (en) * 2003-11-24 2009-03-11 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method of purifying pravastatin
SI1697383T1 (sl) * 2003-12-05 2014-09-30 Biocon Limited Postopek za čiščenje takrolimusa
WO2006046130A2 (en) * 2004-10-29 2006-05-04 Ranbaxy Laboratories Limited Process for the preparation of pravastatin
TW200640854A (en) * 2005-02-09 2006-12-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of making pravastatin sodium
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
DE102006028817A1 (de) * 2006-06-21 2007-12-27 Evonik Degussa Gmbh Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen
WO2009078033A2 (en) * 2007-12-18 2009-06-25 Themis Medicare Limited Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
EP2274267B1 (en) * 2008-04-02 2012-01-04 DSM IP Assets B.V. Pravastatin extraction
IN2009MU00380A (enExample) * 2009-02-18 2010-04-02
CN102993145B (zh) * 2011-09-19 2015-06-03 北大方正集团有限公司 一种提取纯化洛伐他汀的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
EP0215665B1 (en) * 1985-09-13 1991-11-21 Sankyo Company Limited Hydroxy-ml-236b derivatives, their preparation and use
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) * 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
AU6726398A (en) * 1997-02-20 1998-09-09 Gist-Brocades B.V. Nitrogen feed in statin fermentation
AU9264598A (en) * 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
SI9800046A (sl) * 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
PT1154979E (pt) * 1999-02-03 2005-08-31 Inst Drug Res Ltd Processo microbiano para a preparacao da pravastatina
US6682913B1 (en) * 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
EP1265604B1 (en) * 1999-11-30 2006-10-18 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for recovering statin compounds from a fermentation broth
MXPA03002963A (es) * 2000-10-05 2005-01-25 Biogal Gyogyszergyar Pravastatina de sodio sustancialmente libre de pravastatina lactona y epi-pravastatina, y composiciones que la contienen.

Also Published As

Publication number Publication date
ZA200203912B (en) 2003-08-21
US6444452B1 (en) 2002-09-03
EP1265604A4 (en) 2004-06-16
SK7342002A3 (en) 2004-03-02
JP2006273861A (ja) 2006-10-12
JP4343987B2 (ja) 2009-10-14
ES2239937T1 (es) 2005-10-16
ES2273737T3 (es) 2007-05-16
HUP0204012A3 (en) 2003-12-29
KR20030026920A (ko) 2003-04-03
CA2393057C (en) 2008-01-29
DE60031447T2 (de) 2007-08-30
EP1265604A1 (en) 2002-12-18
JP2003515334A (ja) 2003-05-07
JP2008109948A (ja) 2008-05-15
AU1804601A (en) 2001-06-12
YU39102A (sh) 2006-01-16
RU2002114072A (ru) 2004-07-20
CY1105925T1 (el) 2011-04-06
US20040115781A1 (en) 2004-06-17
US20020187531A1 (en) 2002-12-12
DE04010770T1 (de) 2005-10-20
HUP0204012A2 (hu) 2003-03-28
DE60037687D1 (de) 2008-02-14
PL364918A1 (en) 2004-12-27
DK1265604T3 (da) 2007-02-05
EP1265604B1 (en) 2006-10-18
JP2006055174A (ja) 2006-03-02
ATE382344T1 (de) 2008-01-15
US6689590B2 (en) 2004-02-10
JP3881240B2 (ja) 2007-02-14
MXPA02005283A (es) 2003-10-06
PT1265604E (pt) 2006-12-29
DE60031447D1 (de) 2006-11-30
ATE342717T1 (de) 2006-11-15
JP2004350687A (ja) 2004-12-16
CN1433305A (zh) 2003-07-30
CA2393057A1 (en) 2001-06-07
WO2001039768A1 (en) 2001-06-07
HRP20020454A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
CN1754872A (zh) 从发酵肉汤中回收抑素化合物的方法
US6403825B1 (en) Processes for producing citrate esters
CZ54495A3 (en) Process for preparing and/or purification of clavulanic acid
CN101928302A (zh) N-苄基-9-[2-(二烷基磷酰基甲氧基)烷基]腺嘌呤及其制备方法和应用
DK145199B (da) Fremgangsmaade til fremstilling af et antibiotikum papulacandin dets komponenter papulacandin a,b,c,d og e eller hydrogeneringsprodukter og eller ethere eller estere deraf
EA014980B1 (ru) Энзиматический метод разделения рацемической 3-арил-4-аминомасляной кислоты
US20030204105A1 (en) Method for purification of pravastatin or a pharmacologically acceptable salt thereof
EP0287523B1 (en) Process for producing (-) n-acetylaminocarnitine and (+) n-acetylaminocarnitine
EP1673361B1 (en) A method for the manufacture of lovastatin
EP1481674B1 (en) Process for recovering statin compounds from a fermentation broth
US20050003499A1 (en) Ion-exchange filtration of fermentation broth
RU2522806C1 (ru) Усовершенствованный способ очистки правастатина
JPH04141093A (ja) 有機酸エステルの製造法
SU1011655A1 (ru) Способ получени @ - @ -октилглюкозида
EP1798214A1 (en) Process for recovering statin compounds from a fermentation broth
HK1071522A (en) Process for recovering statin compounds from a fermentation broth
HK1053642A (en) Method of purifying pravastatin or its pharmacologically acceptable salt
WO2006058943A1 (es) Procedimiento para la obtención de pravastatina sódica purificada

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication